Moleculin Biotech, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $5.3M | $19.6M | $7.1M |
| FY2019 | $9.7M | $25.2M | $10.7M |
| FY2020 | $11.3M | $29.0M | $15.2M |
| FY2021 | $5.1M | $84.1M | $70.9M |
| FY2022 | $5.2M | $57.4M | $43.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $5.3M | $19.6M | $7.1M |
| FY2019 | $9.7M | $25.2M | $10.7M |
| FY2020 | $11.3M | $29.0M | $15.2M |
| FY2021 | $5.1M | $84.1M | $70.9M |
| FY2022 | $5.2M | $57.4M | $43.1M |